跳至主要内容
临床试验/NCT01418300
NCT01418300已完成4 期

Comparison of Conventional Triple Therapy Versus Sequential Therapy for H. Pylori in Peptic Ulcer Disease: Prospective Randomized Trial

Jun-Won Chung1 个研究点 分布在 1 个国家目标入组 159 人开始时间: 2010年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
159
试验地点
1
主要终点
the eradication rate by urea breath test

研究概览

简要总结

The purpose of this study is to improve first line Helicobacter pylori eradication rate and to compare the sequential versus conventional triple therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • peptic ulcer diseae
  • two test positive rapid urease test, culture, histology

排除标准

  • lactating or pregnant
  • previous stomach surgery
  • severe underlying disease

研究组 & 干预措施

sequential therapy

Active Comparator

first five day amoxicillin+PPI later five day PPI+clarithromycin+metronidazole

干预措施: sequential versus triple (Drug)

conventional triple thearpy

Active Comparator

PPI+amoxicillin+clarithromycin

干预措施: sequential versus triple (Drug)

结局指标

主要结局

the eradication rate by urea breath test

时间窗: 4-6 week later after completion of therapy

to compare the eradication rate (intention-to-treat and per protocol) by urea breath test at least four weeks after treatment

次要结局

未报告次要终点

研究者

发起方
Jun-Won Chung
申办方类型
Industry
责任方
Sponsor Investigator
主要研究者

Jun-Won Chung

principal investigator

Jeil Pharmacy Co.

研究点 (1)

Loading locations...

相似试验

Comparison of Conventional Triple Therapy Versus... | 临床试验